Sinclair

What Sinclair does

Sinclair (legal entity: Sinclair Pharma Limited) is a global medical aesthetics company headquartered in London, United Kingdom, founded in 1971 and operating as a wholly owned subsidiary of Huadong Medicine Company Limited (Hangzhou, China) since 2020. The company manufactures and commercializes a wide portfolio of injectable and energy-based device (EBD) treatments targeting healthcare professionals, including plastic surgeons, dermatologists, aesthetic physicians, nurses, and dentists. Its product suite spans hyaluronic acid fillers (MaiLi, Perfectha), biostimulators (Lanluma, Ellans\u00e9), thread lifts (Silhouette Soft, Instalift), and energy-based devices for body contouring, hair removal, and skin rejuvenation (Cooltech, Elysion Pro, Primelase Excellence, Reaction, Sculpt&Shape, V-Series, Pr\u00e9ime DermaFacial, EnerJet). Notable proprietary technology includes the OxiFree™ HA cross-linking platform and Smart Springs technology used in the MaiLi filler line, which reportedly requires 24% less product than Juv\u00e9derm Voluma for equivalent cheek augmentation.

Sinclair operates through 26 wholly owned legal entities across 19 countries, with direct sales presence in the UK, France, Germany, Spain, Poland, the US, Brazil, the UAE, Singapore, Korea, and Australia, complemented by distributor networks extending total product reach to more than 55 countries. The business model is B2B: products are sold to clinics and practitioners through direct field sales, regional distributors, and the Sinclair Portal digital resource platform, with end-consumer pricing set by clinics. Supporting the commercial model, Sinclair has built an HCP education ecosystem through Sinclair College (seminars, conferences, webinars with KOLs) and Sinclair Portal (on-demand access to marketing materials, clinical studies, and product assets). CE marking is held for MaiLi, Silhouette Soft, and Lanluma in the EU. Sinclair Pharma is distinct from, and should not be conflated with, the US-based Sinclair Broadcast Group, which is an unrelated entity whose financial data appeared in source materials but does not describe Sinclair Pharma.

Revenue is not publicly disclosed as Sinclair is privately held under Huadong Medicine. Based on headcount of 501-1000 employees, 19-country direct footprint, 14+ branded products, and global distribution to 55+ countries, estimated annual revenue is in the $100M-$250M range, with potential upside into $250M-$500M depending on brand ramp and APAC/LATAM contribution. The company is led by CEO Amber Edwards (per the December 2024 Modern Slavery Statement); a separate leadership data point naming Miguel Pardos as CEO was also present in source materials and may reflect a recent transition, but is not directly verifiable in this dataset.

Name

Sinclair

Legal name

Sinclair Pharma Limited

Website

https://sinclair.com

Company type

Private

Founded year

1971

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Sinclair is a London-headquartered global medical aesthetics company that manufactures and commercializes injectable and energy-based device treatments (hyaluronic acid fillers, biostimulators, thread lifts, and EBD platforms) to healthcare professionals across 55+ countries, operating as a wholly owned subsidiary of Huadong Medicine Company Limited.

Ownership category

akta.pro rank

Product category

Medical Aesthetics

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844), Surgical & Medical Instruments & Apparatus (3841), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Eye & Lip Skincare (CRABAAAC)

akta.pro secondary industries

Hair Care (Shampoo, Conditioner, Styling, Treatments) (CRADANAE), Hair & Scalp Devices/Tools (Dryers, Straighteners, Brushes) (CRABABAG), Men’s Facial Skincare (Cleansers, Moisturizers, Anti-aging) (CRABAGAD)

Keywords

• Medical aesthetics
• Hyaluronic acid fillers
• Biostimulator injectables
• Energy-based aesthetic devices
• Thread lifting treatments

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices13 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Medical Aesthetic Products: Revenue from manufacturing and commercializing aesthetic injectable products and energy-based devices to healthcare professionals and clinics globally
2. Core Advertising Revenue: Revenue from local TV advertising sales, grew 4% YoY in Q1 2026
3. Retransmission Revenue: Fees paid by cable/satellite distributors for the right to broadcast Sinclair's TV stations, grew 2% YoY in Q1 2026
4. Political Advertising: Revenue from political campaign advertising, expected to benefit from 2026 midterm election cycle
5. Sports Broadcasting Rights: Revenue from sports content including Tennis Channel and FIFA World Cup advertising

Go-to-market motion2 records

Distribution channels6 records

Marketing channels6 records

Core offering

Sinclair manufactures and commercializes a global portfolio of injectable aesthetic products (hyaluronic acid fillers, poly-L-lactic acid biostimulators, polycaprolactone fillers, and absorbable thread lifts) and energy-based devices (cryolipolysis, diode laser, radiofrequency, multi-platform systems) sold to healthcare professionals and clinics in more than 55 countries. The portfolio supports the full aesthetic journey from facial rejuvenation to body contouring and is complemented by professional education and digital resource platforms for practitioners.

Product overview

Sinclair is a global medical aesthetics company that manufactures and commercializes a wide portfolio of injectable and Energy-Based Device (EBD) treatments. The product portfolio comprises injectables and threads including MaiLi (hyaluronic acid fillers with OxiFree technology), Lanluma (poly-L-lactic acid biostimulator), Ellansé (polycaprolactone filler), Perfectha (HA fillers), Silhouette Soft, and Instalift (thread lifts). The EBD portfolio includes Cooltech/Cooltech Define (cryolipolysis), Elysion Pro (laser), Primelase Excellence (diode laser), Reaction (radiofrequency), Sculpt&Shape, V-Series (multi-platform system), Préime DermaFacial, and EnerJet. Supporting platforms include Sinclair College (education) and Sinclair Portal (digital resource hub). Products are available in more than 55 countries through direct presence and distributor networks, with Sinclair being a wholly owned subsidiary of Huadong Medicine Company Limited (Hangzhou, China).

Differentiator

Problem solved

Functional benefit

Brands

• MaiLi: Portfolio of four advanced HA fillers designed for physicians to craft patient visions with luxurious precision.
• Lanluma
• Ellansé
• Perfectha
• Silhouette Soft
• Cooltech
• Cooltech Define
• Elysion Pro
• Primelase Excellence
• Reaction
• Sculpt&Shape
• V-Series
• Sinclair College
• Sinclair Portal
• Sinclair Live
• Préime DermaFacial
• Instalift

Products and services

• MaiLi
• Lanluma Poly-L-lactic acid (PLLA) biostimulator injectable for healthcare professionals performing facial and body collagen-stimulating treatments, with effects lasting up to two years.
• Ellansé Polycaprolactone-based dermal filler that combines immediate wrinkle correction with stimulation of natural type I collagen for long-lasting skin elasticity, used by aesthetic physicians.
• Perfectha Hyaluronic acid dermal filler range used by healthcare professionals for facial contouring and wrinkle correction.
• Silhouette Soft Absorbable thread lift with bidirectional cones for lifting and tissue regeneration in the mid-face, lower face, neck, and brow, used by aesthetic physicians.
• Cooltech Cryolipolysis energy-based device for non-invasive fat reduction and body contouring using controlled cooling, used by aesthetic clinics.
• Cooltech Define Advanced cryolipolysis system for refined non-invasive body contouring and fat reduction, used by aesthetic clinics.
• Elysion Pro Aesthetic laser device for hair removal and skin treatments used in clinical aesthetic practices.
• Primelase Excellence Diode laser platform for hair removal and aesthetic skin treatments used by aesthetic clinics.
• Reaction Radiofrequency energy-based device for skin tightening and body contouring treatments used by aesthetic clinics.
• Sculpt&Shape Body contouring energy-based device for fat reduction and skin tightening used by aesthetic clinics.
• V-Series Multi-platform energy-based aesthetic device system combining multiple treatment technologies for comprehensive clinical use.
• Pr?ime DermaFacial Advanced derma-facial device for aesthetic facial procedures introduced at the IMCAS World Congress.
• EnerJet Jet-technology device for scar treatment and skin rejuvenation used by aesthetic clinics.
• Instalift Thread lifting product for facial tissue suspension and rejuvenation used by aesthetic physicians.

Quantifiable outcome

• MaiLi fillers demonstrated 24% less product required compared to Juvéderm Voluma for equivalent cheek augmentation results
• +4 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered strategic, minor and core.

• EdgeBeam WirelessstrategicStrategic or Co-development Partner · 7 April 2026EdgeBeam acquired the Broadspan distribution platform from Sinclair, accelerating its go-to-market timeline for national data distribution network utilizing ATSC 3.0 broadcast infrastructure. The acquisition doubled EdgeBeam's technical headcount and included the software suite and core engineering team.
• Colorado Drivers (Fuel Contamination Incident)minorOthersSinclair distribution center in Colorado was identified as the source of contaminated fuel (gasoline mixed with diesel) affecting multiple gas stations. Settlement offers are being extended to affected drivers.
• Amazon Prime VideocoreChannel Partner/ Reseller/ DistributorTennis Channel launched on Amazon Prime Video platform, achieving record DTC subscribers and 19% YoY viewership growth in March 2026.
• E.W. Scripps CompanystrategicStrategic or Co-development PartnerSinclair expressed strategic interest in a potential transaction with E.W. Scripps. The E.W. Scripps Company rejected Sinclair's acquisition offer which included a 240% premium over Scripps' share price, preferring to pursue its standalone strategy.

Scale indicators10 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Galderma: Privately held global dermatology and aesthetics company offering Restylane (HA fillers), Sculptra (PLLA biostimulator, direct competitor to Lanluma) and a broad skin-health portfolio — a direct competitor across Sinclair's injectables and biostimulator franchises.
• BTL Aesthetics: Global leader in non-invasive body contouring and EBD (Emsculpt, Emface, Exilis) — directly competes with Sinclair's Cooltech, Cooltech Define, Sculpt&Shape and Reaction in the energy-based body-contouring category.
• Evolus: US-listed aesthetics company built around the Jeuveau neuromodulator and the recently launched Evolysse HA filler line — competes with Sinclair's injectables portfolio in physician offices.
• Revance Therapeutics: Aesthetic-focused company offering the RHA Collection of resilient HA fillers and Daxxify neuromodulator — a direct injectorables competitor and a recent target of strategic M&A interest, illustrating valuation dynamics in the aesthetics segment.
• InMode: Public medical aesthetics device company specializing in minimally invasive RF, laser and IPL platforms (Morpheus8, BodyTite, Evoke) — directly competes with Sinclair's Reaction, V-Series, Elysion Pro and Primelase EBD lines.
• Merz Aesthetics: Global aesthetics player with Belotero (HA filler), Radiesse (CaHA filler/biostimulator), Ultherapy and BTL co-marketed devices — directly competes with Sinclair's Ellansé and MaiLi in physician-dispensed injectables.
• Teoxane: Swiss-based private aesthetics company with a focused HA filler portfolio (Teosyal) and complementary cosmeceuticals — closely comparable to Sinclair in size, private ownership profile and premium Swiss positioning versus MaiLi.
• Hugel: Korean aesthetics and biopharmaceutical company producing Botulax (toxin), dermal fillers and biostimulators with strong APAC distribution — a regional and increasingly global competitor across Sinclair's injectables and biostimulator franchises.
• Allergan Aesthetics (AbbVie): Acquired by AbbVie in 2020, Allergan Aesthetics is the global market leader in HA fillers (Juvéderm, the direct comparator to MaiLi), biostimulators, toxins and body-contouring devices — the most direct head-to-head competitor across Sinclair's portfolio.
• Cynosure: Global aesthetics device company (acquired by HEALIFE and Hologic) offering laser hair removal, skin revitalization and body-contouring platforms — a direct competitor to Sinclair's Elysion Pro, Primelase and Sculpt&Shape energy-based devices.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Instagraminstagram.com/mysinclairskin
• Xx.com/instaliftus
• LinkedInlinkedin.com/company/sinclair-ltd

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries29 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sinclair